Corpus ID: 55927873

Effects of Withaferin A on A549 Cellular Proliferation and Apoptosis in Non-small Cell Lung Cancer Cells

@inproceedings{Cai2014EffectsOW,
  title={Effects of Withaferin A on A549 Cellular Proliferation and Apoptosis in Non-small Cell Lung Cancer Cells},
  author={Y. Cai and Zhao-ying Sheng and Y. Chen and C. Bai},
  year={2014}
}
Lung cancer is the leading cause for tumor-associated deaths, in which non-small cell lung cancer (NSCLC) accounts for 85% and most patients are in advanced stages with poor therapeutic efficacy when diagnosed (Jemal et al., 2010; Cho et al.,2013; Lu et al., 2013; Wang et al., 2013; Yan et al., 2013; Kim et al., 2014). Though there has been great development in clinical treatment of NSCLC, its prognosis is still unsatisfactory due to the low rate of 5-year survival in clinic (Verdecchia et al… Expand

Figures and Tables from this paper

References

SHOWING 1-10 OF 15 REFERENCES
Apoptosis of human gallbladder carcinoma GBC-SD cells induced by withaferin A and its possible mechanism
Metabolic alterations in mammary cancer prevention by withaferin A in a clinically relevant mouse model.
Withaferin A, a steroidal lactone from Withania somnifera, induces mitotic catastrophe and growth arrest in prostate cancer cells.
Clinical study on mannan peptide combined with TP regimen in treating patients with non-small cell lung cancer.
Withaferin A inhibits matrix metalloproteinase-9 activity by suppressing the Akt signaling pathway.
Phase II study on Javanica oil emulsion injection (Yadanzi®) combined with chemotherapy in treating patients with advanced lung adenocarcinoma.
PI3K-Akt pathway: Its functions and alterations in human cancer
...
1
2
...